Scientists test drug mix safety for liver patients
NCT ID NCT07295873
Summary
This early study aims to understand how a new drug for liver scarring (hydronidone) interacts with four common hepatitis B medications when taken together. Researchers will measure drug levels in the blood of 64 healthy Chinese volunteers to see if the drugs affect each other. The results will help determine safe dosing combinations for future patients with chronic hepatitis B and liver scarring.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B LIVER FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Gaobo Hospital
Beijing, 100000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.